[1] Roth G A, Mensah G A, Johnson C O, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update From the GBD 2019 Study. J Am Coll Cardiol 2020; 76: 2982−3021. doi: 10.1016/j.jacc.2020.11.010 [2] Zhao D, Liu J, Wang M, et al. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol 2019; 16: 203−212. doi: 10.1038/s41569-018-0119-4 [3]

United Nations, Goal 3: Ensure healthy lives and promote well-being for all at all ages, 2015. http://www.un.org/sustainabledevelopment/health/(accessed July 11, 2022).

[4]

The State Council of the People’s Republic of China, State council issues plan to prevent chronic diseases, 2017. http://english.www.gov.cn/policies/latest_releases/2017/02/14/content_281475567482818.htm (accessed July 11, 2022).

[5] Cook W K, Kerr W C, Karriker-Jaffe K J, et al. Racial/ethnic variations in clustered risk behaviors in the U. S. Am J Prev Med 2020; 58: e21−e29. doi: 10.1016/j.amepre.2019.08.020 [6]

Lv J, Yu C, Guo Y, et al. Adherence to healthy lifestyle and cardiovascular diseases in the Chinese population. J Am Coll Cardiol 2017; 69: 1116−1125.

[7] Livingstone K M, Abbott G, Ward J, et al. Unhealthy lifestyle, genetics and risk of cardiovascular disease and mortality in 76, 958 individuals from the UK biobank cohort study. Nutrients 2021; 13: 4283. doi: 10.3390/nu13124283 [8] Chiuve S E, Rexrode K M, Spiegelman D, et al. Primary prevention of stroke by healthy lifestyle. Circulation 2008; 118: 947−54. doi: 10.1161/CIRCULATIONAHA.108.781062 [9] Eguchi E, Iso H, Tanabe N, et al. Healthy lifestyle behaviours and cardiovascular mortality among Japanese men and women: the Japan collaborative cohort study. Eur Heart J 2012; 33: 467−77. doi: 10.1093/eurheartj/ehr429 [10] Zhang X, Lu J, Wu C, et al. Healthy lifestyle behaviours and all-cause and cardiovascular mortality among 0.9 million Chinese adults. Int J Behav Nutr Phys Act 2021; 18: 162. doi: 10.1186/s12966-021-01234-4 [11] Chiuve S E, McCullough M L, Sacks F M, et al. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications. Circulation 2006; 114: 160−7. doi: 10.1161/CIRCULATIONAHA.106.621417 [12] King D E, Mainous AG III, Geesey M E. Turning back the clock: adopting a healthy lifestyle in middle age. Am J Med 2007; 120: 598−603. doi: 10.1016/j.amjmed.2006.09.020 [13] Hulsegge G, Looman M, Smit H A, et al. Lifestyle changes in young adulthood and middle age and risk of cardiovascular disease and all-cause mortality: the Doetinchem Cohort Study. J Am Heart Assoc 2016; 5: e002432. doi: 10.1161/JAHA.115.002432 [14] Ding X, Fang W, Yuan X, et al. Associations between healthy lifestyle trajectories and the incidence of cardiovascular disease with all-cause mortality: a large, prospective, Chinese cohort study. Front Cardiovasc Med 2021; 8: 790497. doi: 10.3389/fcvm.2021.790497 [15]

Zhang H, He M, Zhang X. Association of lifestyle change with incident stroke and its subtypes. Chinese Jo urnal of Disease Control & Prevention 2021; 25: 259−265.

[16] Yang X, Li J, Hu D, et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR project (prediction for ASCVD risk in China). Circulation 2016; 134: 1430−1440. doi: 10.1161/CIRCULATIONAHA.116.022367 [17]

Yang Y, Wang G, Pan X, China food compostion 2002. Peking University Medical Press: Beijing, China, 2002; 186.

[18] Ainsworth B E, Haskell W L, Herrmann S D, et al. 2011 Compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc 2011; 43: 1575−81. doi: 10.1249/MSS.0b013e31821ece12 [19]

Chinese Preventive Medicine Association, Branch of Heart Disease Prevention and Control Chinese Preventive Medicine Association, Society C D. [Chinese guideline on healthy lifestyle to prevent cardiometabolic diseases]. Zhonghua Yu Fang Yi Xue Za Zhi 2020; 54(3): 256−277. [In Chinese].

[20] Brenner H, Gefeller O, Greenland S. Risk and rate advancement periods as measures of exposure impact on the occurrence of chronic diseases. Epidemiology 1993; 4: 229−236. doi: 10.1097/00001648-199305000-00006 [21] Discacciati A, Bellavia A, Orsini N, et al. On the interpretation of risk and rate advancement periods. Int J Epidemiol 2016; 45: 278−284. doi: 10.1093/ije/dyv320 [22] Spiegelman D, Hertzmark E, Wand H C. Point and interval estimates of partial population attributable risks in cohort studies: examples and software. Cancer Cau ses Control 2007; 18: 571−579. doi: 10.1007/s10552-006-0090-y [23] Li Y, Wang D D, Ley S H, et al. Potential Impact of Time Trend of Life-Style Factors on Cardiovascular Disease Burden in China. J Am Coll Cardiol 2016; 68: 818−833. doi: 10.1016/j.jacc.2016.06.011 [24] Han C, Liu F, Yang X, et al. Ideal cardiovascular health and incidence of atherosclerotic cardiovascular disease among Chinese adults: the China-PAR project. Sci China Life Sci 2018; 61: 504−514. doi: 10.1007/s11427-018-9281-6 [25]

Ebrahim S, Taylor F, Ward K, et al. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev 2011; CD001561.

[26] Moll van Charante E P, Richard E, Eurelings L S, et al. Effectiveness of a 6-year multidomain vascular care intervention to pr event dementia (preDIVA): a cluster-randomised controlled trial. Lancet 2016; 388: 797−805. doi: 10.1016/S0140-6736(16)30950-3 [27] Lehtisalo J, Rusanen M, Solomon A, et al. Effect of a multi-domain lifestyle intervention on cardiovascular risk in older people: the FINGER trial. Eur Heart J 2022; 43: 2054−2061. doi: 10.1093/eurheartj/ehab922 [28] Gao Y, Chen Y, Hu M, et al. Lifestyle trajectories and ischaemic heart diseases: a prospective cohort study in UK Biobank. Eur J Prev Cardiol 2023; 30: 393−403. doi: 10.1093/eurjpc/zwad001 [29] Gellert C, Schottker B, Holleczek B, et al. Using rate advancement periods for communicating the benefits of quitting smoking to older smokers. Tob Control 2013; 22: 227−230. doi: 10.1136/tobaccocontrol-2012-050572